அண்ணா பெர்கேன்ப்ளித் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அண்ணா பெர்கேன்ப்ளித். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அண்ணா பெர்கேன்ப்ளித் Today - Breaking & Trending Today

ImmunoGen, inc (IMGN) Q2 2021 Earnings Call Transcript

ImmunoGen, inc (IMGN) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Mark Enyedy , Andy Hsieh , Joe Catanzaro , John Newman , Joseph Catanzaro Piper Sandler , Phillip Harter , Kennen Mackay , Rebecca Arend , Yige Guo Guggenheim , Piper Sandler , Anna Berkenblit , Swayampakula Ramakanth , Kelly Shi Jefferies , John Newman Canaccord Genuity , Dsusan Altschuller , Courtney Okonek , Michael Schmidt , Kelly Shi , Bristol Myers , William Blair , Andy Hsieh William Blair Company Analyst , Swayampakula Ramakanth Hc Wainwright Co , Corporate Communications , Company Analyst , Roche Diagnostics Corporation , Immunogen Second Quarter ,

Novel Anti-Cancer Drugs Permeate the Marketplace

Share this article
Share this article
NEW YORK, May 25, 2021 /PRNewswire/ The cancer therapeutics market is one of the largest segments of the biotechnology industry. According to the National Cancer Institute, roughly 1.8 million people were diagnosed with cancer in the United States in 2020 alone. However, the oncology and cancer drug market is expected to grow largely due to the surge in cancer research, the rise in the geriatric population worldwide, as well as the increase in collaboration between pharmaceutical companies. Moreover, the high market growth potential in developing nations, a rise in the number of pipeline products, and an upsurge in demand for personalized medicines are expected to create new opportunities for market players. And, according to data published by Market Industry Reports, the cancer therapeutics market was estimated to be valued at over USD 140 Billion in 2019 and is anticipated to grow at a CAGR of ~7.7% from 2019 to 2030. Sunshine Biop ....

United States , Melissa Aucoin , Anna Berkenblit , Steve Slilaty , National Cancer Institute , American Society Of Clinical Oncology , Sunshine Biopharma Inc , Immunogen Inc , Company Interviews , Trillium Therapeutics Inc , Drug Administration , National Ovarian Cancer Coalition , Yuhan Corporation , Verastem Inc , Immuneoncia Therapeutics Inc , Sorrento Therapeutics Inc , Market Industry Reports , Trillium Therapeutics , Sorrento Therapeutics , Fortune Business , Sunshine Biopharma , Breakthrough Therapy , National Ovarian Cancer , Clinical Oncology , Virtual Annual Meeting , Senior Vice President ,

Immunogen Inc (IMGN) Q1 2021 Earnings Call Transcript

Operator
Good morning, and welcome to the ImmunoGen s First Quarter of 2021 Financial and Operating Results Conference Call. Today s conference is being recorded. At this time, I d like to turn the call over to Courtney O Konek, Senior Director of Corporate Communications and Investor Relations. Ma am, please go ahead.
Courtney O Konek
Senior Director of Corporate Communications and Investor Relations
Good morning, and thank you for joining today s call. Earlier today, we issued a press release that includes a summary of our recent progress in first quarter 2021 financial results. This press release and a recording of this call can be found under the Investors & Media section of our website at immunogen.com. ....

Mark Enyedy , Andy Hsieh , Joe Catanzaro , John Newman , Jessica Fye , John Newman Cannacord , Phillip Harter , Philip Harter , Andy Hsieh William Blair , Dave Omalley , Luke Brennan Jpmorgan , Joe Catanzaro Piper Sandler , Rebecca Arend , Keenen Mackay , Luke Brennan , Piper Sandler , Anna Berkenblit , Michael Schmidt Guggenheim , Kelly Shi Jefferies , Swayampakula Ramakanth , Dsusan Altschuller , Dana Farber , Courtney Okonek , Michael Schmidt , Kelly Shi , William Blair ,

Immunogen Inc (IMGN) Q4 2020 Earnings Call Transcript

Operator
Good morning and welcome to ImmunoGen s Fourth Quarter and Full-Year 2020 Financial and Operating Results Conference Call. Today s conference is being recorded.
At this time, I would like to turn the call over to Courtney O Konek, Senior Director of Corporate Communications and Investor Relations. Please go ahead.
Courtney O Konek
Senior Director of Corporate Communications and Investor Relations
Good morning, and thank you for joining today s call. Earlier today, we issued a press release that includes a summary of our recent progress and fourth quarter and full-year 2020 financial results. This press release and a recording of this call can be found under the Investor and Media section of our website at immunogen.com. ....

Mark Enyedy , Andy Hsieh , John Newman , Jessica Fye , Kennen Mackay , Yige Guo Guggenheim , Lucy Gilbert , Anna Berkenblit , Swayampakula Ramakanth , Biren Amin , Jonathan Chang , Dsusan Altschuller , John Newman Canaccord Genuity , Courtney Okonek , Michael Schmidt , William Blair , Andyt Hsieh William Blair Company Analyst , Biren Amin Jefferies Company Analyst , Boehringer Ingelheim , Md Anderson Cancer Center , Swayampakula Ramakanth Hc Wainwright Co , Corporate Communications , Company Analyst , Immunogen Inc , Fourth Quarter , Operating Results Conference ,